Oyster Point Pharma, Inc. Gains 38.56%
Mon, Nov 07, 2022 at 07:51 PM
Oyster Point Pharma, Inc. (OYST:NASDAQ) rocketted at $11.57, a gain of 38.6%. On Mon, Nov 07, 2022, OYST:NASDAQ hit a New 2-Week High of $11.57. The stock appeared on our News Catalysts scanner on Mon, Nov 07, 2022 at 09:31 AM in the 'ACQUISITION' category. From Tue, Oct 25, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
About Oyster Point Pharma, Inc. (OYST:NASDAQ)
Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.
Top 10 Gainers:
- Creatd Inc. (CRTD:NASDAQ), 48.39%
- Arqit Quantum Inc. (ARQQ:NASDAQ), 46.87%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Veru Inc. (VERU:NASDAQ), 39.52%
- Oyster Point Pharma, Inc. (OYST:NASDAQ), 38.56%
- Phunware, Inc. (PHUN:NASDAQ), 38.33%
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 32.55%
- Funko, Inc. (FNKO:NASDAQ), 28.66%
- ACM Research, Inc. (ACMR:NASDAQ), 27.69%
- GigaCloud Technology Inc (GCT:NASDAQ), 26.61%